Veterinary Medicine Information website

Albiotic 330 mg/100 mg Intramammary Solution

Authorised
  • NEOMYCIN SULFATE
  • Lincomycin hydrochloride

Product identification

Medicine name:
Albiotic 330 mg/100 mg Intramammary Solution
Active substance:
  • NEOMYCIN SULFATE
  • Lincomycin hydrochloride
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    115.96
    milligram(s)
    /
    1.00
    Syringe
  • Lincomycin hydrochloride
    359.63
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        48
        hour
      • Milk
        72
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Sterile aqueous solution in 10 ml high density polyethylene syringes with a fixed cannula (plastets), packaged as 100plastets in an outer cardboard box also containing alcohol pads for teat disinfection. Cap LDPE, brombutyl rubber stopper.
  • Sterile aqueous solution in 10 ml high density polyethylene syringe with a fixed cannula (plastet), packaged as 1 plastet in an outer cardboard box also containing alcohol pad for teat disinfection. Cap LDPE, brombutyl rubber stopper.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10782/028/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 19/10/2025
Download